| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |